These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18457381)

  • 1. Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailability.
    Charrier N; Clarke B; Cutler L; Demont E; Dingwall C; Dunsdon R; East P; Hawkins J; Howes C; Hussain I; Jeffrey P; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    J Med Chem; 2008 Jun; 51(11):3313-7. PubMed ID: 18457381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides.
    Rueeger H; Lueoend R; Rogel O; Rondeau JM; Möbitz H; Machauer R; Jacobson L; Staufenbiel M; Desrayaud S; Neumann U
    J Med Chem; 2012 Apr; 55(7):3364-86. PubMed ID: 22380629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second generation of BACE-1 inhibitors part 3: Towards non hydroxyethylamine transition state mimetics.
    Charrier N; Clarke B; Cutler L; Demont E; Dingwall C; Dunsdon R; Hawkins J; Howes C; Hubbard J; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3674-8. PubMed ID: 19406640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE-1 hydroxyethylamine inhibitors using novel edge-to-face interaction with Arg-296.
    Clarke B; Cutler L; Demont E; Dingwall C; Dunsdon R; Hawkins J; Howes C; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4639-44. PubMed ID: 20579874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors.
    Rueeger H; Rondeau JM; McCarthy C; Möbitz H; Tintelnot-Blomley M; Neumann U; Desrayaud S
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1942-7. PubMed ID: 21388807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics.
    Charrier N; Clarke B; Cutler L; Demont E; Dingwall C; Dunsdon R; Hawkins J; Howes C; Hubbard J; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3664-8. PubMed ID: 19428244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.
    Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1017-21. PubMed ID: 18166458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.
    Ng RA; Sun M; Bowers S; Hom RK; Probst GD; John V; Fang LY; Maillard M; Gailunas A; Brogley L; Neitz RJ; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Adler M; Yao N; Zmolek W; Nakamura D; Quinn KP; Sauer JM; Bova MP; Ruslim L; Artis DR; Yednock TA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4674-9. PubMed ID: 23856050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs).
    Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Hawkins J; Hussain I; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Soleil V; Smith KJ; Stanway S; Stemp G; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1011-6. PubMed ID: 18171614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells.
    Beswick P; Charrier N; Clarke B; Demont E; Dingwall C; Dunsdon R; Faller A; Gleave R; Hawkins J; Hussain I; Johnson CN; MacPherson D; Maile G; Matico R; Milner P; Mosley J; Naylor A; O'Brien A; Redshaw S; Riddell D; Rowland P; Skidmore J; Soleil V; Smith KJ; Stanway S; Stemp G; Stuart A; Sweitzer S; Theobald P; Vesey D; Walter DS; Ward J; Wayne G
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1022-6. PubMed ID: 18171615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model.
    Truong AP; Tóth G; Probst GD; Sealy JM; Bowers S; Wone DW; Dressen D; Hom RK; Konradi AW; Sham HL; Wu J; Peterson BT; Ruslim L; Bova MP; Kholodenko D; Motter RN; Bard F; Santiago P; Ni H; Chian D; Soriano F; Cole T; Brigham EF; Wong K; Zmolek W; Goldbach E; Samant B; Chen L; Zhang H; Nakamura DF; Quinn KP; Yednock TA; Sauer JM
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6231-6. PubMed ID: 20833041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.
    Charrier N; Clarke B; Demont E; Dingwall C; Dunsdon R; Hawkins J; Hubbard J; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3669-73. PubMed ID: 19477642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloid.
    Weiss MM; Williamson T; Babu-Khan S; Bartberger MD; Brown J; Chen K; Cheng Y; Citron M; Croghan MD; Dineen TA; Esmay J; Graceffa RF; Harried SS; Hickman D; Hitchcock SA; Horne DB; Huang H; Imbeah-Ampiah R; Judd T; Kaller MR; Kreiman CR; La DS; Li V; Lopez P; Louie S; Monenschein H; Nguyen TT; Pennington LD; Rattan C; San Miguel T; Sickmier EA; Wahl RC; Wen PH; Wood S; Xue Q; Yang BH; Patel VF; Zhong W
    J Med Chem; 2012 Nov; 55(21):9009-24. PubMed ID: 22468639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
    Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
    Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.
    Sandgren V; Agback T; Johansson PO; Lindberg J; Kvarnström I; Samuelsson B; Belda O; Dahlgren A
    Bioorg Med Chem; 2012 Jul; 20(14):4377-89. PubMed ID: 22698785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of monomeric derivatives to probe memoquin's bivalent interactions.
    Bolognesi ML; Chiriano G; Bartolini M; Mancini F; Bottegoni G; Maestri V; Czvitkovich S; Windisch M; Cavalli A; Minarini A; Rosini M; Tumiatti V; Andrisano V; Melchiorre C
    J Med Chem; 2011 Dec; 54(24):8299-304. PubMed ID: 22054058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
    Sund C; Belda O; Borkakoti N; Lindberg J; Derbyshire D; Vrang L; Hamelink E; Åhgren C; Woestenenk E; Wikström K; Eneroth A; Lindström E; Kalayanov G
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6721-7. PubMed ID: 23010268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1.
    Kortum SW; Benson TE; Bienkowski MJ; Emmons TL; Prince DB; Paddock DJ; Tomasselli AG; Moon JB; LaBorde A; TenBrink RE
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3378-83. PubMed ID: 17434734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 1,4-dihydropyridine derivatives as BACE-1 inhibitors.
    Choi SJ; Cho JH; Im I; Lee SD; Jang JY; Oh YM; Jung YK; Jeon ES; Kim YC
    Eur J Med Chem; 2010 Jun; 45(6):2578-90. PubMed ID: 20303626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.